0001950047-24-004666.txt : 20240612
0001950047-24-004666.hdr.sgml : 20240612
20240612162222
ACCESSION NUMBER: 0001950047-24-004666
CONFORMED SUBMISSION TYPE: 144
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20240612
DATE AS OF CHANGE: 20240612
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Avidity Biosciences, Inc.
CENTRAL INDEX KEY: 0001599901
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 461336960
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 144
SEC ACT: 1933 Act
SEC FILE NUMBER: 001-39321
FILM NUMBER: 241038691
BUSINESS ADDRESS:
STREET 1: 10578 SCIENCE CENTER DRIVE
STREET 2: SUITE 125
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-401-7900
MAIL ADDRESS:
STREET 1: 10578 SCIENCE CENTER DRIVE
STREET 2: SUITE 125
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: Avidity Biosciences LLC
DATE OF NAME CHANGE: 20161227
FORMER COMPANY:
FORMER CONFORMED NAME: Avidity NanoMedicines LLC
DATE OF NAME CHANGE: 20140211
REPORTING-OWNER:
COMPANY DATA:
COMPANY CONFORMED NAME: Boyce Sarah
CENTRAL INDEX KEY: 0001629383
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 144
MAIL ADDRESS:
STREET 1: C/O IONIS PHARMACEUTICALS, INC.
STREET 2: 2855 GAZELLE COURT
CITY: CARLSBAD
STATE: CA
ZIP: 92010
144
1
primary_doc.xml
144
0001629383
XXXXXXXX
LIVE
0001599901
AVIDITY BIOSCIENCES INC
001-39321
10578 Science Center Drive, Suite 125
San Diego
CA
92121
8584017900
SARAH BOYCE
Director
Officer
Common
Morgan Stanley Smith Barney LLC Executive Financial Services
1 New York Plaza
8th Floor
New York
NY
10004
100000
2892000.00
95636748
06/12/2024
NASDAQ
Common
06/12/2024
Exercise of Stock Options
Issuer
N
100000
06/12/2024
Cash
N
10b5-1 Sales for SARAH BOYCE
10578 Science Center Drive, Suite 125
San Diego
CA
92121
Common
06/04/2024
28000
767779.60
10b5-1 Sales for SARAH BOYCE
10578 Science Center Drive, Suite 125
San Diego
CA
92121
Common
05/07/2024
28000
715050.00
10b5-1 Sales for SARAH BOYCE
10578 Science Center Drive, Suite 125
San Diego
CA
92121
Common
04/02/2024
28000
734918.80
The securities to be sold were and will be received upon the exercise of stock options over the next three months.
The date of acquisition and payment was and will be the date of exercise/sale.
06/12/2024
06/09/2023
/s/ Sarah Boyce